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Summary 
Growth factor receptor tyrosine kinases can form stable 
associations with intracellular proteins that contain src 
homology (SH) 2 domains, including the p85 regulatory 
subunit of phosphatidylinositol (PI)-3 kinase. The activa- 
tion of this enzyme by growth factors is evaluated in 
PC12 pheochromocytoma cells and NIH 3T3 fibroblasts 
expressing the pp140c-‘& nerve growth factor (NGF) re- 
ceptor (3T3-c-f&). NCF causes the rapid stimulation of 
PI-3 kinase activity detected in anti-phosphotyrosine, 
but not in anti-trk, immunoprecipitates. This effect coin- 
cides with the tyrosine phosphorylation of two proteins, 
with molecular masses of of 100 kd and 110 kd, that 
coimmunoprecipitate with ~85. Similar phosphoryla- 
tion patterns are induced when an immobilized fusion 
protein containing the amino-terminal SH2 domain of 
p85 is used to precipitate tyrosine-phosphorylated pro- 
teins. Thus, although NCF produces the rapid activation 
of PI-3 kinase through a mechanism that involves tyro- 
sine phosphorylation, there is no evidence for tyrosine 
phosphorylation of ~85, or for its liganddependent asso- 
ciation with the NGF receptor. Perhaps another phos- 
phoprotein may link the NGF receptor to this enzyme. 
Introduction 
Although the mechanisms by which neurotrophins 
such as nerve growth factor (NGF) supportthe survival 
and differentiation of sympathetic and sensory neu- 
rons remain elusive, it is recognized that early changes 
in protein phosphorylation ultimately play an im- 
portant role in the cellular actions of the growth fac- 
tor. NGF increases the phosphorylation of several cel- 
lular proteins (Halegoua and Patrick, 1980; Nakanishi 
and Guroff, 1985; Landreth and Rieser, 1985) and is 
known to stimulate the activities of several serine/ 
threonine kinases (Lee et al., 1985; Hama et al., 1986; 
Matsuda and Guroff, 1987; Rawland et al., 1987; Aletta 
et al., 1988; Heasley and Johnson, 1989a, 1989b; Vulliet 
et al., 1989; Miyasaka et al., 1990; Ohmichi et al., 
199213). Recent evidence (Kaplan et al., 1991a; Klein et 
al., 1991; Weskamp and Reichardt, 1991; Ohmichi et 
al., 1992b) indicates that these serinelthreonine phos- 
phorylations result from the direct binding of NGF to 
its high affinity receptor, pp140trk. This receptor is a 
protein tyrosine kinase, and both its activity and tyro- 
sine autophosphorylation are increased in response 
to NGF (Kaplan et al., 1991b; Ohmichi et al., 1991b). 
The precise tyrosine phosphorylation substrates 
that initiate the differentiative responses of neurons 
to neurotrophins have yet to be identified. However, 
the many similarities in eary phosphorylation events 
produced by differentiative agents Ii ke NGF and mito- 
genie agents like epidermal growth factor (EGF) sug- 
gest that subtle differences in signaling events are 
required to distinguish different cellular fates. One 
mechanism for the divergence in signals initiated by 
tyrosine kinase receptors may be their differential in- 
teractions with effector proteins containing src ho- 
mology 2 (SH2) domains. Three such signaling pro- 
teins, phospholipase C (PLQ-~1 (Wahl et al., 1988; 
Margolis et al., 1989; Meisenhelder et al., 1989; Wahl 
et al., 1989a, 1989b), GTPase activating protein of ras 
(Molly et al., 1988; Trahey et al., 1988; Ellis et al., 1990), 
and phosphatidylinositol (PI)-3 kinase (Bjorge et al., 
1990), are phosphorylated on tyrosine residues in re- 
sponse to numerous growth factors and can form sta- 
ble associations with receptors in a growth factor- 
dependent manner (Kumjian et al., 1989; Kaplan et al., 
1990; Kazlauskas et al., 1990; Margolis et al., 1990a; 
Cantley et al., 1991; Hu et al., 1992) via an interaction 
with the SH2 domain (Coughlin et al., 1989; Anderson 
et al., 1990; Margolis et al., 1990b; Moran et al., 1990; 
Escobedo et al., 1991a, 1991 b; Otsu et al., 1991; Skolnik 
et al., 1991). We recently reported that NGF stimulates 
the association of its high affinity pp140c-*rk receptor 
with the SH2 domains of PLC-~1 in PC12 pheochromo- 
cytoma cells (Ohmichi et al., 1991b) and further that 
the constitutively active ~70~-“~ oncogene product is 
also associated with PLC-~1 through its SH2 domains 
(Ohmichi et al., 1991a). Moreover, the NGF-dependent 
association of pp140c-frk with PLC-yl correlates with 
the tyrosine phosphorylation of a 38 kd phosphopro- 
tein, which itself coprecipitates with both pp140c-frk 
and the SH2 domains of PLC-~1 in response to NGF 
(Ohmichi et al., 1992c). 
Although there was no detectable association of the 
NGF receptor with CTPase activating protein of ras 
(Ohmichi et al., 1991b), preliminary results indicated 
that NGF stimulated the phosphorylation of two pro- 
teins that specifically bound to the p85 subunit of PI-3 
kinase (Ohmichi et al., 1992c). This enzyme phospho- 
rylates PI on the D3 position of the inositol ring, lead- 
ing to the formation of the novel phosphoinositides 
PI-3P, PI-3,4P2, and PI-3,4,5P3. Although the precise 
functions of these lipids remain unknown, the expo- 
sure of cells to growth factors (Kaplan et al., 1987; 
Whitman et al., 1987; Auger et al., 1989) or oncogenic 
transformation (Fukui et al., 1991) causes their accu- 
mulation. Moreover, mutational analyses of the plate- 
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Figure 1. NGF, EGF, and Insulin Stimulate Pi-3 Kinase Activity in 
Anti-Phosphotyrosine lmmunoprecipitates of PC12 Ceils 
PC12 cells were grown in 150 mm dishes. NGF (100 nM), EGF (10 
nM), or insulin (100 nM) was directly added to the medium and 
incubated forthe indicated times at 37OC. Lysateswere immuno- 
precipitated with anti-phosphotyrosine antiserum, and PI-3 ki- 
nase activity was measured by incubating with [y-32P]ATP and PI 
as described in Experimental Procedures. One unit of activity is 
defined as nmoles of PI-3P per min (~10~~). In the lower panel 
are shown autoradiographs of the region of the thin-layer chro- 
matograph containing PI-3P. Results are from a single experi- 
ment that was repeated three times. 
1989), EGF (Bjorge et al., 1990), and colony stimulating 
factor (Varticovski et al., 1989; Reedijk et al., 1990; 
Shurtleff et al., 1990) receptors indicated a strong cor- 
relation between stimulation of cell growth and PI-3 
kinase activation. Since NGF, EGF, and insulin para- 
doxically share a number of common early signaling 
pathways (Saltiel and Decker, 1991), we have com- 
pared the actions of these three growth factors on 
stimulation of PI-3 kinase activity and association of 
tyrosine-phosphorylated proteins with its 85 kd regu- 
latory protein. These results indicate that the high 
affinity NGF receptor differentially associates with 
SHZ-containing proteins, via direct or indirect mecha- 
nisms. 
Results 
The NGF-dependent activation of PI-3 kinase was 
also explored in 3T3 cells that were transfected with 
the p~l40~-~~~ cDNA. These cells express the 140 kd 
high affinity receptor, but contain no low affinity p75 
receptor (Ohmichi et al., 1992b). Exposure of 3T3-c-trk 
cells to NGF also caused an increase in PI-3 kinase 
activity, although the time course was slightly faster 
than that observed in PC12 cells, occurring maximally 
at 1 min (Figure 2). These data provide further evi- 
dence that the pp140 crrk receptor is both necessary 
and sufficient for the early signaling events in NGF 
action. 
NCF Stimulates PI-3 Kinase Activity 
Via Its pp140c-fd Receptor 
NGF binding to the pp140c-frk receptor stimulates its To explore further the mechanism of activation of 
association with the SH2 domains of PLC-Tl in both PI-3 kinase in response to NGF, PC12 or 3T3-c-t& cells 
PC12 (Ohmichi et al., 1991b) and 3T3 fibroblasts ex- were treated with NGF and subsequently immunopre- 
pressing the human pp140c-‘rk (3T3-c-t&) (Ohmichi et cipitated with anti-phosphotyrosine, anti-trk, or anti- 
al., 1992c) as well as its phosphorylation on tyrosine sera raised against the 85 kd regulatory subunit of PI-3 
(Kim et al., 1991; Ohmichi et al., 1991 b). To explore the kinase prior to assay of PI-3 kinase activity (Figure 3). 
involvement of other SH2 proteins in NGF action, we Although NGF produced a marked increase in PI-3 
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Figure 2. NCF Stimulates PI-3 Kinase Activity in Anti-phospho- 
tyrosine lmmunoprecipitates of PC12 and 3T3-c-trk Cells 
PC12 and 3T3-c-trk cells were grown in 150 mm dishes. NGF (100 
nM) was directly added to the medium and incubated for the 
indicated times at 37OC. Lysates were immunoprecipitated with 
anti-phosphotyrosine antiserum, and PI-3 kinase activity was 
measured as described in Figure 1. Autoradiographs are shown 
in a lower panel. 
exposure to NGF, EGF, and insulin. Following hor- 
monal treatment, lysates were precipitated with anti- 
phosphotyrosine antiserum, and the resulting immu- 
noprecipitates were assayed for phosphorylation of 
PI (Figure 1). In PC12 cells, NGF rapidly activated PI-3 
kinase activity that was detected in anti-phosphotyro- 
sine immunoprecipitates. This effect was observed 
after 1 min of exposure and was maximal at 5 min, but 
declined thereafter. Similarly, both EGF and insulin 
also stimulated the activity of this enzyme in anti- 
phosphotyrosine immunoprecipitates. Effects of these 
hormones were maximal after only 1 min of exposure 
and declined thereafter. 
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Figure 3. NCF-Stimulated PI-3 Kinase Activity Is Not Detected in 
Anti-trk or Anti-p85 lmmunoprecipitates from PC12 or 3T3-c-trk 
Cells 
PC12 and 3T3-c-trk cells were grown in 150 mm dishes. NGF (100 
nM) was directly added to the medium and incubated for 5 min 
in PC12 cells or 1 min in 3T3-c-t& cells at 37OC. Lysates were 
immunoprecipitated with anti-phosphotyrosine, anti-trk, or anti- 
p85 antisera, and PI-3 kinase activity was measured as described 
in Figure 1. 
munoprecipitates from both cell types, no significant 
increase was observed in anti-trk immunoprecipitates. 
In addition, precipitation with a glutathione S-trans- 
ferase (GST) fusion protein containing the SH2 do- 
main of p85 also brought down NGF-stimulated PI-3 
kinase activity (data not shown). Immunoprecipita- 
tion with anti-p85 antisera brought down significant 
enzyme activity in the absence of NGF; however, there 
was no significant increase upon NGF treatment. The 
elevated activity observed in these immunoprecipi- 
tates may reflect activation of the enzyme by antibody 
binding to the p85 subunit, mimicking the activation 
produced by binding of tyrosine-phosphorylated pro- 
teins to the p85 SH2 domain. 
NCF Stimulates the Association of 
Tyrosine-Phosphorylated Proteins with 
the 85 kd Subunit of PI-3 Kinase 
Recent studies indicate that binding of certain growth 
factors to their receptors can induce a stable associa- 
tion with p85 of PI-3 kinase (Kaplan et al., 1987; Es- 
cobedo et al., 1991a) as well as the phosphorylation of 
this protein (Kazlauskas and Cooper, 1989, 1990). To 
determine whether the activation of PI-3 kinase by 
NGF occurs through a similar mechanism, PC12 cells 
were treated with NGF, EGF, or insulin, and lysates 
were precipitated with anti-p85 antiserum (Figure 4). 










Figure 4. NGF, EGF, and Insulin Stimulate the Tyrosine Phos- 
phorylation of Proteins in PC12 Cells That Coprecipitate with p85 
PC12 cells were grown in 150 mm dishes. NGF (100 nM), ECF (IO 
nM), or insulin (100 nM) was directly added to the medium and 
incubated for the indicated times at 37’C. Lysates were immuno- 
precipitated with anti-p85 antiserum and subject to SDS-PAGE, 
followed by immunoblotting with anti-phosphotyrosine antise- 
rum, as described in Experimental Procedures. 
resed on polyacrylamide gels, and tyrosine-phospho- 
rylated proteins were detected by immunoblotting 
with anti-phosphotyrosine antiserum. In cells treated 
with NGF,twotyrosine-phosphorylated proteinswere 
detected that migrated with apparent M, values of 
100 and 110. These phosphoproteins were observed 
within 1 min of exposure to NGF and rapidly declined 
thereafter. EGF also stimulated the tyrosine phosphor- 
ylation of pplOOand ~~110, although not aseffectively 
as NGF. In insulin-treated PC12cells, pplOOand ppll0 
were not detected, although a 185 kd tyrosine-phos- 
phorylated protein, tentatively identified as insulin 
receptor substrate 1 (Sun et al., 1991), was found in 
anti-p85 immunoprecipitates within 1 min of expo- 
sure. The phosphorylation of this protein also de- 
clined thereafter, although it appeared to be more 
stable than the NGF-dependent phosphorylation of 
the 100 and 110 kd proteins. 
To evaluate the cell specificity of the NGF- and EGF- 
dependent tyrosine phosphorylations of pplO0 and 
~~110, the effects of these growth factors were evalu- 
ated in other cell types expressing their respective 
receptors. 3T3-c-trk cells and NI H 3T3 cells transfected 
with the human EGF receptor (3T3/hEGFR) (Decker et 
al.,1990)weretreated with NGFor EGF,and the lysates 
were precipitated with anti-p85 antiserum (Figure 5). 
The addition to 3T3-c-trk cells of 100 nM NGF for 1 min 
NeUKWl 
772 













& % & % kb 
EGF 
0202020 2 c lmin 5min 








Figure 5. NCF Stimulates the Tyrosine Phosphorylation of Proteins in 3T3-c-&k Cells That Associate with the p85 SH2 Domain 
PC12, 3T3-c-trk, and 3T3/hEGFR cells were grown in 150 mm dishes. NGF (100 nM) or EGF (IO nM) was directly added to the medium 
and incubated for the indicated times at 37OC. (A) In lanes 1-4, lysates were immunoprecipitated with anti-p85 antiserum and subject 
to SDS-PAGE, followed by immunoblotting with anti-phosphotyrosine antiserum. In lanes 5 and 6, a GST-p85 SH2 fusion protein 
immobilized with glutathione-Sepharose beads was mixed with lysates from cells. Bound proteins were subject to SDS-PAGE followed 
by antiphosphotyrosine immunoblotting. (B) Lysates were immunoprecipitated with preimmune rabbit serum (lanes 1 and 2) or anti-trk 
antiserum (lanes 3 and 4). The resulting supernatants were subsequently precipitated with anti-p85 antiserum (lanes 5-8) and subject 
toSDS-PAGE,followed byimmunoblottingwith anti-phosphotyrosineantiserum. (C) Lysatesfrom3T3/hECFRcelIswereimmunoprecipi- 
tated with anti-p85 antiserum and subject to SDS-PAGE, followed by immunoblotting with anti-phosphotyrosine antiserum. 
induced the tyrosine phosphorylation of the two pro- 
teins (~~100 and ~~110) as well as additional proteins 
with molecular masses of 160 kd and 140 kd (Figure 
5A). To explore whether the 140 kd phosphoprotein 
identified in anti-p85 immunoprecipitates of 3T3-c-trk 
cells was the trk proto-oncogene, lysates from control 
and NGF-treated cells were preimmunoprecipitated 
with preimmune or anti-trk antisera, and the resulting 
supernatants were subsequently precipitated with 
anti-p85 antiserum (Figure 5B). Preimmunoprecipita- 
tion with anti-trk antiserum brought down the NGF- 
dependent tyrosine phosphorylated pp140c-“k and its 
associated 38 kd protein (Ohmichi et al., 1992c) (Figure 
58, lane 4), but did not clear the 140 kd protein from 
the anti-p85 immunoprecipitates (Figure 5B, lane 8), 
suggesting that this 140 kd band is not the trk proto- 
oncogene. 
In contrast to PC12 cells, treatment of 3T3/hEGFR 
cells with EGF caused the coprecipitation of its tyro- 
sine-phosphorylated receptor in the anti-p85 immu- 
noprecipitate (Figure 5C). These results suggested 
that the association of the EGFR with p85 occurs only 
in cells overexpressing this receptor, similar to what 
was observed for the association of this receptor with 
PLC-~1 (Ohmichi et al., 1991 b). Furthermore, the phos- 
phorylation of p85 in response to NGF was not ob- 
served in either PC12 or 3T3-c-trk cells, despite the 
marked increase in PI kinase activity detected in the 
anti-phosphotyrosine immunoprecipitates. The pres- 
ence of the p85 protein in anti-p85 immunoprecipi- 
tates from both cell types was confirmed by Western 
blotting with the same antiserum (Figure 6). More- 
over, this antiserum can recognize phosphorylated 
~85, since the EGF-stimulated tyrosine phosphoryla- 
tion of p85 was detected in immunoprecipitates from 
3T3/hEGFR cells (Figure 5C). Interestingly, Western 
blotting of anti-trk immunoprecipitates from NGF- 
treated PC12 or 3T3-c-&k cells with anti-p85 revealed 
no evidence for ~85. Additionally, blotting of anti-p85 
immunoprecipitates from NGF-treated cells with anti- 
trk antiserum revealed no evidence for pp140c-“rk (data 
not shown). However, the results in 3T3 cells overex- 
pressing EGFR suggest that overexpression of the NGF 
receptor in cells may lead to NGF-dependent phos- 
phorylation of p85 and direct association with its re- 
ceptor. 
The concentration dependence of the effect of NGF 
on the appearance of pp1001110 in the anti-p85 immu- 
NGF Stimulates PI-3 Kinase 
773 
A B 
Ceil: PC12 3T3-c-t& 
I I I 
I.P.: Pre A-p85 Pre A-p85 
mm-- 















1234 1 2 3 4 
Figure 6. Detection of p85 in lmmunoprecipitates by Western 
Blotting 
PC12 (A) and 3T3-c-trk (6) cells were grown in 150 mm dishes. 
NGF (100 nM) was directly added to the medium and incubated 
for 1 min at 37OC, as described in Figure 4. Lysates were immuno- 
precipitated with preimmune rabbit serum (lanes 1 and 2) or 
anti-p85 antiserum (lanes 3 and 4) and subject to SDS-PAGE, 
followed by immunoblotting with anti-p85 antiserum, as de- 
scribed in Experimental Procedures. 
noprecipitates was evaluated in PC12 cells (Figure 7). 
NGF caused a dose-dependent increase in the phos- 
phorylation of these proteins, which was observed 
with as little as 1 nM NGF and increased up to concen- 
trations of 100 nM. 
To explore further the nature of the association of 
these NGF- and ECF-dependent phosphoproteins 
with the p85 subunit of PI-3 kinase, we examined the 
effect of NGF on the binding of tyrosine-phosphor- 
ylated proteins to an immobilized fusion protein con- 
taining the amino-terminal SH2 domain of p85 (Figure 
8). Cells were treated with the growth factors, and 
lysates were incubated with the immobilized fusion 
protein prior to SDS-polyacrylamide gel electropho- 
resis (PAGE) and immunoblotting with anti-phospho- 
tyrosine antiserum. The addition to PC12 cells of NGF 
or EGF induced the association of both ppll0 and 
pplO0 with the p85 fusion protein, although neither 
receptor was detected in these precipitates. More- 
over, the addition to 3T3-c-trk cells of NGF induced 
the association of ppll0 and pplO0 as well as pp140 
and pp160 (Figure 5A, lanes 5 and 6). In contrast, treat- 
ment of 3T3lhEGFR cells with EGF caused the associa- 
tion of its tyrosine-phosphorylated receptor with the 
fusion protein, as well as additional proteins, includ- 
ing ~~110. Additionally, treatment of Swiss 3T3 cells 
with PDGF also stimulated the association of its tyro- 
sine-phosphorylated receptor (molecular mass, 190 
kd) with the SH2 domain fusion protein. In insulin- 
treated PC12 and HlRc cells (overexpressing the hu- 
man insulin receptor), both the g subunit of the insu- 
lin receptor (molecular mass, 95 kd) and a protein 
tentatively identified as insulin receptor substrate 1 











Figure 7. TheDoseDependenceof NGF-lnducedTyrosinePhos- 
phorylation of pplO0 and ppll0 in PC12 Cells 
PC12cells were treated with the indicated concentrations of NCF 
for 1 min at37’C. Lysateswere immunoprecipitated with anti-p85 
antiserum and subject to SDS-PAGE, followed by immunoblot- 
ting with anti-phosphotyrosine antiserum. 
the 110 kd protein, although the 100 kd NGF- and 
ECF-sensitive protein was not found. 
Discussion 
Like many other growth factors with tyrosine kinase 
receptors, NGF rapidly stimulates the activity of PI-3 
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Figure 8. NGF, ECF, and Insulin Induce the Association of Tyro- 
sine-Phosphorylated Proteins with the p85 SH2 Domain 
PC12, HIRc, 3T3/hECFR, and Swiss 3T3 cells were grown in 150 
mm dishes. NCF (100 nM), EGF (10 nM), insulin (100 nM), or PDGF 
(10 nM) was directly added to the medium and incubated for 
1 min at 37’C. Lysates were incubated with a GST-~85 fusion 
protein immobilized with glutathione-Sepharose beads. The as- 
sociation of tyrosine-phosphorylated proteins with the fusion 
protein was evaluated as described in Figure 5. 
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kinase. Although the role of the novel lipid products 
of this enzyme, as well as the mechanism of activation, 
remains poorly understood, there is little doubt that 
cellular tyrosine phosphorylation plays an important 
role (Kaplan et al., 1987; Auger et al., 1989; Coughlin 
et al., 1989; Bjorge et al., 1990; Endermann et al., 1990; 
Kazlauskas and Cooper, 1990; Hu et al., 1992). NGF-, 
EGF-,and insulin-stimulated PI-3 kinaseactivitieswere 
detected in anti-phosphotyrosine immunoprecipitates, 
suggesting that the enzyme is itself phosphorylated 
or can associate with one or more growth factor- 
dependent tyrosine-phosphorylated proteins. How- 
ever, in the case of NGF, there is no evidence that 
the PI-3 kinase itself can directly associate with the 
tyrosine-phosphorylated NGF receptor. Although it is 
possible that the anti-trk antibody employed in these 
studies blocks PI-3 kinase activity or association with 
the receptor, this antiserum did not precipitate PI-3 
kinase activity. Moreover, immunoblotting of anti-trk 
immunoprecipitates from NGF-treated cells with anti- 
p85 antiserum, or blotting of anti-p85 immunoprecipi- 
tates with anti-trk antiserum, revealed no evidence 
for the association of ~85. In addition, the pp140c-“k 
protein was not detected in anti-p85 or p85 SH2 fusion 
protein precipitates from NGF-treated cells, in con- 
trast to the identification of the tyrosine-phosphor- 
ylated receptor in anti-PLC-yl or PLC-~1 SH2 fusion 
protein precipitates (Ohmichi et al., 1991b). The lack 
of NGF receptor association with p85 is not surprising, 
since the tyrosine kinase domain of trk lacks the nu- 
cleotide consensus sequence (EYMXM) thought to be 
required for p85 binding, although it does have a re- 
gion of some similarity (FEYMRHGD) around Tyr-595. 
Additionally, there is also no evidence that p85 itself 
undergoes phosphorylation on tyrosine in response 
to NGF, since an 85 kd tyrosine-phosphorylated band 
was not detected in anti-p85 immunoprecipitates in 
response to the growth factors, despite the presence 
of this protein, as verified by immunoblotting. 
Interestingly, NGF did cause the tyrosine phosphor- 
ylation of two proteins at 100 kd and 110 kd, detected 
by their coimmunoprecipitation with anti-p85 antise- 
rum or association with the p85 SH2 fusion protein. 
Theappearanceof these phosphoproteins temporally 
correlated with stimulation of PI-3 kinase activity, al- 
though therewere discrepancies regarding the extent 
of phosphorylation observed with NGF and EGF and 
their relative activations of the enzyme. It is important 
to note, however, that our ability to detect phosphory- 
lation depends upon association of these proteins 
with the p85 protein, so the extent of phosphorylation 
observed here may be misleading. However, the SH2 
association of pplO0 and ppll0 was specific for ~85, 
since these bands were not detected in anti-PLC-yl or 
anti-GTPase activating protein (of ras) immunoprecip- 
itates and were not associated with immobilized fu- 
sion proteins containing SH2 domains of these pro- 
teins (Ohmichi et al., 1991b). 
It is possible that the 110 kd protein detected in 
these precipitates isthecatalytic subunitof PI-3 kinase 
(Carpenter et al., 1990), although there is no direct 
evidence to support this speculation. Moreover, an- 
other interesting possibility is that ~~100, which is 
phosphorylated in response to both NGF and EGF, 
may represent a specific p85-binding protein that me- 
diates activation of PI-3 kinase by these factors. In this 
regard, pplO0 may be analogous to the pp185 insulin 
receptor substrate 1, which contains up to ten p85 
binding motifs and is likely to mediate the insulin- 
dependent activation of PI-3 kinase (Endermann et al., 
1990; Ruderman et al., 1990). 
The stimulation of PI-3 kinase activity represents 
another early cellular response that NGF shares with a 
numberof mitogenicfactors, notably, EGFand insulin 
(Saltiel and Decker, 1991). These factors produce simi- 
lar, but not identical tyrosine phosphorylations (Miya- 
saka et al., 1991; Ohmichi et al., 1992a, 1992c) and simi- 
larly stimulate the serine/threonine phosphorylation 
and activation of microtubule-associated protein ki- 
nase (Miyasaka et al., 1990), S6 kinase (Matsuda and 
Guroff, 1987), protein kinase C (Hama et al., 1986; 
Heasley and Johnson, 1989a), and raf-1 kinase (Oh- 
michi et al., 199213). Despite these numerous similarities 
in early signaling events, the downstream cellular ac- 
tions of these factors in PC12 cells are quite different. 
Most notable is the distinction between the differ- 
entiative activity of NGF and the mitogenic activity 
of EGF. One possible clue for solving this apparent 
paradox may lie in the differential associations of 
these tyrosine kinase receptors with proteins con- 
taining SH2 domains. Studies in PC12 and 3T3-c-trk 
cells indicate that the NGF receptor associates with 
PLC-~1 (Ohmichi et al., 1991 b), does not associate with 
GTPase activating protein of ras (Ohmichi et al., 
1991b), and may activate PI-3 kinase via an indirect 
mechanism, whereas both the EGF and insulin recep- 
tors exhibit quite different patterns of SH2 binding 
in these cells (Ohmichi et al., 1992c). Although the 
downstream events that allow cells to distinguish 
growth and differentiative signals remain a mystery, 
it is likely that the close examination of divergent sig- 




[y-j2P]ATP (300 Ci/mol) was from New England Nuclear (Ban- 
nockburn, IL). ‘251-labeled protein A (30 mCi/mg) was from Amer- 
sham (Arlington Heights, IL). NCF 2.5s was from Bioproducts for 
Science(lndianapolis, IL). Receptor grade EGFwasfrom Collabo- 
rative Research (Lexington, MA). Recombinant human PDGF-!3P 
homodimer was from Bachem morrance, CA). Insulin was from 
Eli Lilly (Indianapolis, IN). Silica gel thin-layer chromatography 
plates were from EM Separations (Gibbstown, NJ).Anti-phospho- 
tyrosine monoclonal antiserum and anti-p85 polyclonal antise- 
rum were from Upstate Biotechnology (Lake Placid, NY). All 
other reagents were purchased from Sigma (St. Louis, MO) and 
were the highest quality available. Anti-trk antiserum (Ohmichi 
et al., 1991a, 1991b) was developed as described previously. The 
pCEX plasmid expressingthe amino-terminal SH2domain of p85 
in a CST fusion protein was the generous gift of Drs. B. Margolis 
and J. Schlessinger and contained the amino-terminal SH2 do- 
main of the p85 subunit (Hu et al., 1992). 
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Cell Culture 
NIH 3T3 cells were transfected with the plasmid pC012-trk con- 
taining the full-length human trk cDNA (generous gift of Dr. Luis 
Parada) (3T3-c-trk) (Ohmichi et al., 1992b) in the pCO12 vector 
as described previously (Velu et al., 1987). NIH 3T3 cells were 
transfected with the normal human EGFR (3T3/hECFR) (Decker 
et al., 1990). PC12 cells, 3T3-c-trk cells, NIH/hEGFR cells, and 
Swiss-3T3 cells were grown in Dulbecco’s modified Eagle’s me- 
dium containing 4500 mg per liter of o-glucose and 10% fetal 
bovine serum. Rat fibroblasts expressing 300,000 normal human 
insulin receptors (HIRc), which were the generous gift of Dr. 
Donald A. McClain (Maegawa et al., 1988; McClain et al., 1988), 
were grown in Dulbecco’s modified Eagle’siF medium with 
10% fetal bovine serum and 100 nM methotrexate. 
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Assay of PI-3 Kinase Activity 
Cells weregrown in 150 mm dishes. Growth factorsweredirectly 
added to the medium and incubated for the indicated times at 
37OC. After hormonal treatment, the medium was removed, and 
cells were washed twice with 12 ml of icecold phosphate- 
buffered saline before the addition of 1 ml of Nonidet P-40 buffer 
(20 mM Tris [pH 7.5],150 mM NaCI, 1% Nonidet P-40,5 mM EDTA, 
100 WM sodium orthovanadate, 10 wglml aprotinin, 10 pglml leu- 
peptin, and 1 mM phenylmethylsulfonyl fluoride). Lysates were 
centrifuged at 10,008 x g for 10 min. The resulting supernatants 
were incubated for 1 hr with the indicated antisera. Following 
the incubation, protein A-Sepharose beads were added for 30 
mim with mixing, and immune complexes bound to the beads 
were washed three times with Nonidet P-40 buffer, once with 
phosphate-buffered saline, once with 0.5 M LiCI/O.l M Tris (pH 
7.5), once with distilled water, and once with 0.1 M NaCIIO.1 mM 
EDTAIl mM Tris (pH 7.5). The PI-3 kinase assay was performed 
by adding to the immunoprecipitate 50 ~1 of PI kinase buffer (10 
mM Tris [pH 7.51, 0.2 mM EGTA, 100 mM NaCl), 0.5 mglml PI, 20 
mM MgCI,, and 10 PM [yP*P]ATP (10 )rCi per assay), followed by 
the addition of 100 PI of chloroform, methanol, HCI (100:200:2), 
and then 100 ~1 of chloroform and 100 ~1 of water were added. 
The resulting organic was dried, resuspended in 50 ~1 of chloro- 
form, methanol (l:l), and spotted on a silica gel thin-layer chro- 
matography plate that was developed in chloroform, methanol, 
water, ammonium hydroxide (43:38:7:5). 32P-labeled PI-3 phos- 
phate was visualized by autoradiography and compared with an 
iodine-stained standard. 
Anti-Phosphotyrosine lmmunoblots 
Cells were grown in 150 mm dishes. Before hormonal treatment, 
the medium was replaced with serum-free medium and incu- 
bated for 1 hr. Unless otherwise indicated, 100 nM NGF, 10 nM 
EGF, 10 nM PDGF, or 100 nM insulin was directly added to the 
medium and incubated for 1 min at 37OC. After hormonal treat- 
ment, the medium was removed, and cells were washed twice 
with 12 ml of ice-cold phosphate-buffered saline before theaddi- 
tion of 1 ml of HNTG buffer (50 mM HEPES [pH 7.51, 150 mM 
NaCI, 10% glycerol, 1% Triton X-100,1.5 mM MgCI,, 1 mM EDTA, 
10 PM sodium pyrophosphate, 200 PM sodium orthovanadate, 
100 mM NaF, 30 mM pnitrophosphate, IO pg/ml aprotinin, IO 
pg/ml leupeptin,and 1 mM phenylmethyl sulfonyl fluoride)(Mar- 
golis et al., 1990a). Lysates were centrifuged at 10,000 x g for IO 
min. Supernatants were incubated for 1 hr with the indicated 
antisera. Following the incubation, protein A-Sepharose beads 
were added for 30 min with mixing, and immune complexes 
bound to the beads were washed three times with 1 ml of HNTG 
buffer. Immunecomplexes were solubilized in 25 ~1 of Laemmli 
sample buffer (Laemmli et al., 1970) and electrophoresed on 8% 
SDS polyacryamidegels. Transfer to nitrocellulose paper, immu- 
noblotting with anti-phosphotyrosine antiserum, and washing 
were performed as described (Decker et al., 1990). For blotting 
of tyrosine-phosphorylated proteins binding to the bacterially 
expressed SH domain of p85, supernatants were incubated for 
90 min with glutathione-Sepharose beads, to which the CST- 
p85 fusion protein had been bound. The beads were washed 
three times with 1 ml of HNTG buffer, and samples were resolved 
on 8% SDS gels. 
Aletta, T. M., Lewis, S. A., Cowan, N. J., and Greene, L. A. (1988). 
Nerve growth factor regulates both the phosphorylation and 
steady-state levels of microtubuleassociated protein 1.2 (MAP1.2). 
1. Cell Biol. 706, 1573-1581. 
Anderson, D., Koch, C. A., Grey, L., Ellis, C., Moran, M. F., and 
Pawson, T. (1990). Binding of SH2 domains of phospholipase 
C-yl, GAP, and Src to activated growth factor receptors. Science 
250, 979-982. 
Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P., and Cantley, 
L. C. (1989). PDGF-dependent tyrosine phosphorylation stimu- 
lates production of novel polyphosphoinositides in intact cells. 
Cell 57, 167-175. 
Bjorge, J. D., Chan, T., Antczak, M., Kung, H., and Fugita, D. J. 
(1990). Activated type 1 phosphatidylinositol kinase is associated 
with the epidermal growth factor (ECF) receptor following EGF 
stimulation. Proc. Natl. Acad. Sci. USA 87, 3816-3820. 
Cantley, L.C., Auger, K. R., Carpenter, C., Duckworth, B., Crazi- 
ani, A., Kapeller, R., and Soltoff, S. (1991). Oncogenes and signal 
transduction. Cell 64, 281-302. 
Carpenter, C. L., Duckworth, B. C., Auger, K. R., Cohen, B., 
Schaffhausen, B. S., and Cantley, L. C. (1990). Purification and 
characterization of phosphoinositide 3-kinase from rat liver. J. 
Biol. Chem. 265, 19704-19711. 
Coughlin, S. R., Escobedo, J. A., and Williams, L. T. (1989). Role 
of phosphatidylinositol kinase in PDGF receptor signal transduc- 
tion. Science 243, 1191-1194. 
Decker, S. J., Ellis, C., Pawson, T., and Velu, T. (1990). Effects of 
substitution of threonine 654 of the epidermal growth factor 
receptor on epidermal growth factor-mediated activation of 
phospholipase C. J. Biol. Chem. 265, 7009-7015. 
Ellis, C., Moran, M., McCormick, F., and Pawson, T. (1990). Phos- 
phorylation of GAP and GAP-associated proteins by trans- 
forming and mitogenic tyrosine kinases. Science 343, 377-381. 
Endermann, G., Yonezawa, K., and Roth, R. A. (1990). Phosphati- 
dylinositol kinase or an associated protein is a substrate for the 
insulin receptor tyrosine kinase. 1. Biol. Chem. 265, 396-400. 
Escobedo, J. A., Kaplan, D. R., Kavanaugh, W. M., Turck, C. W., 
and Williams, L. T. (1991a). A phosphatidylinositol-3 kinase binds 
to platelet-derived growth factor receptors through a specific 
receptor sequence containing phosphotyrosine. Mol. Cell. Biol. 
71, 1125-1132. 
Escobedo, J. A., Navankasattusas, S., Kavanaugh, W. M., Milfay, 
D., Fried, V. A., and Williams, L. T. (1991b). cDNA cloning of a 
novel 85 kd protein that has SH2 domains and regulates binding 
of PI3-kinase to the PDCF p-receptor. Cell 65, 75-82. 
Fukui, Y., Saltiel, A. R., and Hanafusa, H. (1991). Phosphatidylino- 
sitol-3 kinase is activated in v-src, v-yes, and v-fps transformed 
chicken embryo fibroblasts. Oncogene 6, 407-411. 
Halegoua, S., and Patrick, J. (1980). Nervegrowth factor mediates 
phosphorylation of specific proteins. Cell 22, 571-581. 
Hama, T., Huang, K. P., and Guroff, C. (1986). Protein kinase C as 
a component of a nerve growth factor-sensitive phosphorylation 
system in PC-12 cells. Proc. Natl. Acad. Sci. USA 83, 2353-2357. 
Heasley, L. E., and Johnson, C. L. (1989a). Regulation of protein 
kinase C by nerve growth factor, epidermal growth factor, and 
phorbol esters in PC-12 pheochromocytoma cells. J. Biol. Chem. 
264, 8646-8652. 
Heasley, L. E., and Johnson, C. L. (1989b). Detection of nerve 
growth factor and epidermal growth factor regulated protein 
kinases in PC-12 cells with synthetic peptide substrates. Mol. 
Pharmacol. 35, 331-338. 
Hu, P., Margolis, B., Skolnik, E. Y., Lammers, R., Ullrich, A., and 
Schlessinger, J. (1992). Interaction of phosphatidylinositol 3-ki- 
nase-associated p85 with ECF and PDGF receptors. Mol. Cell. 
Biol. 72, 981-990. 
Kaplan, D. R., Whitman, M., Schaffhausen, B., Pallas, D. C., 
White, M., Cantley, L., and Roberts, T. M. (1987). Common ele- 
ments in growth factor stimulation and oncogenic transforma- 
tion: 85 kd phosphoprotein and phosphatidylinositol kinase ac- 
tivity. Cell 50, 1021-1029. 
Kaplan, D. R., Morrison, D. K., Wong, G., McCormick, F., and 
Williams, L. T. (1990). PDCF B-receptor stimulates tyrosine phos- 
phorylation of GAP and association of GAP with a signaling com- 
plex. Cell 67, 125-133. 
Kaplan, D. R., Martin-Zanca, D., and Parada, L. F. (1991a). Tyro- 
sine-phosphorylation and tyrosine kinase activity of trk proto- 
oncogene product induced by NGF. Nature 350, 158-160. 
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., 
and Parada, L. F. (1991b). The trk proto-oncogene product: a sig- 
nal transducing receptor for nerve growth factor. Science 252, 
552-558. 
Kazlauskas, A., and Cooper, J. A. (1989). Autophosphorylation of 
the PDGF receptor in the kinase insert region regulates interac- 
tions with cell proteins. Cell 58, 1121-1133. 
Kazlauskas, A., and Cooper, J. A. (1990). Phosphorylation of the 
PDGF receptor B subunit creates a tight binding site for phospha- 
tidylinositol 3 kinase. EMBO J. 9, 3279-3286. 
Kazlauskas, A., Ellis, C., Pawson, T., and Cooper, 1. A. (1990). 
Binding of GAP to activated PDGF receptors. Science 247,1578- 
1581. 
Kim, U. H., Fink, D., Jr., Kim, H. S., Park, D. J., Contreras, M. L., 
Guroff, C., and Rhee, S. C. (1991). Nerve growth factor stimulates 
phosphorylation of phospholipase C-y in PC12 cells. J. Biol. 
Chem. 266, 1359-1362. 
Klein, R., Jing, S., Nanduri, K. V., O’Rourke, E., and Barbacid, 
M. (1991). The trk protooncogene encodes a receptor for nerve 
growth factor. Cell 65, 189-197. 
Kumjian, D.A., Wahl, M. I., Rhee, S. G., and Daniel, T. 0. (1989). 
Platelet-derived growth factor (PDGF) binding promotes physical 
association of PDGF receptor with phospholipase C. Proc. Natl. 
Acad. Sci. USA 86, 8232-8236. 
Laemmli, U. K. (1970). Cleavage of structural proteins during the 
assembly of the head of bacteriophage T4. Nature 227,680-685. 
Landreth, C. E., and Rieser, G. D. (1985). Nerve growth factor- 
and epidermal growth factor-stimulated phosphorylation of a 
PC12 cytoskeletally associated protein in situ. J. Cell Biol. 700, 
677-683. 
Lee, K.Y., Seeley, D. J., Muller,T. H., Helmer-Matyjek, E., Sabban, 
E., Coldstern, M., and Greene, L. A. (1985). Regulation of tyrosine 
hydroxylase phosphorylation of PC-12 pheochromocytoma cells 
by elevated K+ and nerve growth factor. Mol. Pharmacol. 28,220- 
228. 
Maegawa, H., McCJain, D. A., Freidengerg, G., Olefsky, J. M., 
Napier, M., Lipari, T., Dull, T. J., Lee, J., and Ullrich, A. (1988). 
Properties of a human insulin receptor with a COOH-terminal 
truncation. J. Biol. Chem. 263, 8912-8917. 
Margolis, B., Rhee, S. G., Felder, S., Mervic, M., Lyall, R., Levitzki, 
A., Ullrich, A., Zilberstein, A., and Schlessinger, J. (1989). EGF 
induces tyrosine phosphorylation of phospholipase C-II: a po- 
tential mechanism for ECF receptor signaling. Cell 57,1101-1107. 
Margolis, B., Bellot, F., Honegger, A. M., Ullrich,A., Schlessinger, 
J., and Zilberstein, A. (1990a). Tyrosine kinase activity is essential 
for the association of phospholipase C-y with the epidermal 
growth factor. Mol. Cell. Biol. 70, 435-441. 
Margolis, B., Li, N., Koch, A., Mohammadi, M., Hurwitz, D. R., 
Zilbertein, A., Ullrich,A., Pawson,T., and Schlessinger, J. (1990b). 
The tyrosine phosphorylated carboxyterminus of the ECF recep- 
tor is a binding site for GAP and PLC-y. EMBO J. 9, 4375-4380. 
Matsuda, Y., and Guroff, C. (1987). Purification and mechanism 
of activation of a nerve growth factor-sensitive S6 kinase from 
PC-12 cells. J. Biol. Chem. 262, 2832-2844. 
McClain, D.A., Maegawa, H., Levy, J., Hueckstead, T., Dull, T. J., 
Lee,J., Ullrich,A.,andOlefsky, J.M.(1988).Propertiesofa human 
insulin receptorwith aCOOH-terminal truncation. J. Biol. Chem. 
263, 8904-8911. 
Meisenhelder, J., Suh, P.-G., Rhee, S. G., and Hunter, T. (1989). 
Phospholipase C-y is a substrate for the PDGF and ECF receptor 
protein-tyrosine kinases in vivo and in vitro. Cell 57,1109-1122. 
Miyasaka, T., Chao, M. V., Sherline, P., and Saltiel, A. R. (1990). 
Nerve growth factor stimulates a protein kinase in PC-12 cells 
that phosphorylates microtubule-associated protein-2. J. Biol. 
Chem. 265, 47304747. 
Miyasaka, T., Sternberg, D. W., Miyasaka, J., Sherline, P., and 
Saltiel, A. R. (1991). Nerve growth factor stimulates protein tyro- 
sine phosphorylation in PC-12 pheochromocytoma cells. Proc. 
Natl. Acad. Sci. USA 88, 2653-2657. 
Molly, C. J., Bottaro, D. P., Fleming, T. P., Marshall, M. S., Gibbs, 
J. B., and Aaronson, 5. A. (1988). PDCF induction of tyrosine 
phosphorylation of GTPase activating protein. Nature 342, 711- 
714. 
Moran, M. F., Koch, C. A., Anderson, D., Ellis, C., England, L., 
Martin, C. S., and Pawson, T. (1990). Src homology region 2 do- 
mains direct protein-protein interactions in signal transduction. 
Proc. Natl. Acad. Sci. USA 87, 8622-8626. 
Nakanishi, N., and Guroff, C. (1985). Nerve growth factor- 
induced increase in the cell-free phosphorylation of a nuclear 
protein in PC12 cells. J. Biol. Chem. 260, 7791-7799. 
Ohmichi, M., Decker, S. J., Pang, L., and Saltiel, A. R. (1991a). 
Phospholipase C-y1 directly associates with the p70 trk oncogene 
product through its src homology domains. J. Biol. Chem. 266, 
14858-14861. 
Ohmichi, M., Decker, S. J., Pang, L., and Saltiel, A. R. (1991b). 
Nerve growth factor binds to the 140 kd trk proto-oncogene 
product and stimulates its association with the src homology 
domain of phospholipase C-yl. Biochem. Biophys. Res. Com- 
mun. 779, 217-223. 
Ohmichi, M., Decker, S. J., Pang, L., and Saltiel, A. R. (1992a). 
Inhibitionofthecellularactionsof nervegrowthfactorbystauro- 
sporine and K252A results from the attenuation of the activity of 
the trk tyrosine kinase. Biochemistry 37, 4034-4039. 
Ohmichi, M., Pang, L., Decker, S. J., and Saltiel, A. R. (1992b). 
Nerve growth factor stimulates the activities of the r&-l and the 
mitogen-activated protein kinases via the trk protooncogene. J. 
Biol. Chem. 267, 14604-14610. 
Ohmichi, M., Decker, S. J., and Saltiel, A. R. (1992c). Nerve growth 
factor stimulates the tyrosine phosphorylation of a 38 kD protein 
that specifically associates with the src homology domain of 
phospholipase C-~1. J. Biol. Chem., in press. 
Otsu, M., Hiles, I., Gout, I., Fry, M. J., Ruiz-Larrea, F., Panayotou, 
G., Thompson, A., Dhand, R., Hsuan, J., Totty, N., Smith, A. D., 
Morgan, S. J., Courtneidge, S. A., Parker, P. J., and Waterfield, 
M. D. (1991). Characterization of two 85 kd proteins that associate 
with receptortyrosine kinases, middleT-pp60c-srccomplexes,and 
Pl5kinase. Cell 65, 91-104. 
Rawland, E. A., Muller, T. H., Goldstein, M., and Greene, L. A. 
(1987). Cell-free detection and characterization of a novel nerve 
growth factor-activated protein kinase in PC-12 cells. J. Biol. 
Chem. 262, 7504-7513. 
Reedijk, M., Liu, X., and Pawson, T. (1990). Interactions of phos- 
phatidylinositol kinase, CTPaseactivating (GAP), and CAP-asso- 
ciated proteins with the colony-stimulating factor 1 receptor. 
Mol. Cell. Biol. 70, 560-5608. 
Ruderman, N. B., Kapeller, R., White, M. F., and Cantley, L. C. 
NZF Stimulates PI-3 Kinase 
7; 7 
(1390). Activation of phosphatidylinositol 3-kinase by insulin. 
PIOC. Natl. Acad. Sci. USA 87, 1411-1415. 
Saltiel,A. R.,and Decker, S. J. (1991). Diversity incellularsignaling 
fcr nerve growth factor and insulin: variations on a common 
theme. Mol. Cell. Endocrinol. 87, C197-C202. 
Shurtleff, S. A., Downing, J. R., Rock, C. O., Hawkins, S. A., Rous- 
sel, M. F., and Sherr, C. J. (1990). Structural features of thecolony- 
strmulating factor 1 receptor that affect its association with phos- 
phatidylinositol 3-kinase. EMBO J. 9, 2415-2421. 
Skolnik, E. Y., Margolis, B., Mohammadi, M., Lowenstein, E., 
Fischer, R., Drepps, A., Ullrich, A., and Schlessinger, J. (1991). 
C oning of Pi3 kinase-associated p85 utilizing a novel method 
fc r expression/cloning of target proteins for receptor tyrosine 
kinases. Cell 65, 83-90. 
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., 
M’ilden, P. A., Cahill, D. A., Goldstein, B. J., and White, M. F. 
(1991). Structure of the insulin receptor substrate IRS-1 defines 
a unique signal transduction protein. Nature 352, 73-77. 
Trahey,M.,Wong, C., Halenbeck, R.,Rubinfeld,B, Martin, C. A., 
Ladner, M., Long, C. M., Crosier, W. J., Watt, K., Koths, K., and 
h/cCormick, F. (1988). Molecular cloning of two types of GAP 
complementary DNA from human placenta. Science 242,1697- 
1;‘oo. 
Varticovski, L., Druker, B., Morrison, D., Cantley, L.,and Roberts, 
T. (1989). The colony stimulating factor-l receptor associates with 
and activates phosphatidylinositol-3 kinase. Nature%?, 699-702. 
V&r, T. J., Beguinot, L., Vass, W. C., Willingham, M. C., Merlinto, 
G. T., Pastan, I., and Lowy, D. R. (1987). Epidermal growth factor- 
dependent transformation by a human EGF receptor proto- 
o~icogene. Science 238, 1408-1410. 
Vulliet, P. R., Hall, F. L., Mitchell, J. P., and Hardie, D. G. (1989). 
lcrentification of a novel proline-directed serine/threonine pro- 
tein kinase in rat pheochromocytoma. J. Biol. Chem. 264,16292- 
lb298. 
Wahl, M. I., Daniel, T. O., and Carpenter, C. (1988). Antiphospho- 
tyrosinerecoveryof phospholipaseCactivityafterEGFtreatment 
oi A-431 cells. Science 247, 966-970. 
Wahl, M. I., Nishibe, S., Suh, P. G., Rhee, S. G., and Carpenter, 
C. (1989a). Epidermal growth factor stimulates tyrosine phos- 
pnorylation of phospholipase C-2 independently of receptor in- 
ternalization and extracellularcalcium. Proc. Natl. Acad. Sci. USA 
86, 1568-1572. 
Wahl, M. I., Olashaw, N. E., Nishibe, S., Rhee, S. G., Pledger, 
W. J., and Carpenter, G. (1989b). Platelet-derived growth factor 
induces rapid and sustained tyrosine phosphorylation of phos- 
pholipase C-y in quiescent BALB/c3T3 cells. Mol. Cell. Biol. 9, 
2934-2943. 
Weskamp, G., and Reichardt, L. F. (1991). Evidence that biological 
activity of NGF is mediated through a novel subclass of high 
affinity receptors. Neuron 6, 649-663. 
Whitman, M., Kaplan, D., Roberts, T., and Cantley, L. (1987). Evi- 
dence for two distinct phosphatidylinositol kinases in fibro- 
blasts. Biochem. 1. 247, 165-174. 
